| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113762.1.4.1029.287 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287 |
| version | 20220127 |
| status | active |
| publisher | Joint Commission |
| name | BleedingDisorder |
| title | Bleeding Disorder |
| date | 2022-01-27T01:02:42-05:00 |
| experimental | false |
| Usages | (none) |
This value set contains 37 concepts
| Code | System | Display |
| D66 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor VIII deficiency |
| D67 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor IX deficiency |
| D68.00 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, unspecified |
| D68.01 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 1 |
| D68.020 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 2A |
| D68.021 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 2B |
| D68.022 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 2M |
| D68.023 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 2N |
| D68.029 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 2, unspecified |
| D68.03 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease, type 3 |
| D68.04 | http://hl7.org/fhir/sid/icd-10-cm | Acquired von Willebrand disease |
| D68.09 | http://hl7.org/fhir/sid/icd-10-cm | Other von Willebrand disease |
| D68.1 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor XI deficiency |
| D68.2 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary deficiency of other clotting factors |
| D68.311 | http://hl7.org/fhir/sid/icd-10-cm | Acquired hemophilia |
| D68.312 | http://hl7.org/fhir/sid/icd-10-cm | Antiphospholipid antibody with hemorrhagic disorder |
| D68.318 | http://hl7.org/fhir/sid/icd-10-cm | Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.32 | http://hl7.org/fhir/sid/icd-10-cm | Hemorrhagic disorder due to extrinsic circulating anticoagulants |
| D68.4 | http://hl7.org/fhir/sid/icd-10-cm | Acquired coagulation factor deficiency |
| D68.51 | http://hl7.org/fhir/sid/icd-10-cm | Activated protein C resistance |
| D68.52 | http://hl7.org/fhir/sid/icd-10-cm | Prothrombin gene mutation |
| D68.59 | http://hl7.org/fhir/sid/icd-10-cm | Other primary thrombophilia |
| D68.61 | http://hl7.org/fhir/sid/icd-10-cm | Antiphospholipid syndrome |
| D68.62 | http://hl7.org/fhir/sid/icd-10-cm | Lupus anticoagulant syndrome |
| D68.69 | http://hl7.org/fhir/sid/icd-10-cm | Other thrombophilia |
| D69.0 | http://hl7.org/fhir/sid/icd-10-cm | Allergic purpura |
| D69.1 | http://hl7.org/fhir/sid/icd-10-cm | Qualitative platelet defects |
| D69.2 | http://hl7.org/fhir/sid/icd-10-cm | Other nonthrombocytopenic purpura |
| D69.3 | http://hl7.org/fhir/sid/icd-10-cm | Immune thrombocytopenic purpura |
| D69.41 | http://hl7.org/fhir/sid/icd-10-cm | Evans syndrome |
| D69.42 | http://hl7.org/fhir/sid/icd-10-cm | Congenital and hereditary thrombocytopenia purpura |
| D69.49 | http://hl7.org/fhir/sid/icd-10-cm | Other primary thrombocytopenia |
| D69.51 | http://hl7.org/fhir/sid/icd-10-cm | Posttransfusion purpura |
| D69.59 | http://hl7.org/fhir/sid/icd-10-cm | Other secondary thrombocytopenia |
| D69.6 | http://hl7.org/fhir/sid/icd-10-cm | Thrombocytopenia, unspecified |
| D69.8 | http://hl7.org/fhir/sid/icd-10-cm | Other specified hemorrhagic conditions |
| D69.9 | http://hl7.org/fhir/sid/icd-10-cm | Hemorrhagic condition, unspecified |
Produced 08 Sep 2023